A deep understanding of the healthcare sector's multi-faceted nuances and complexities, combined with decades of corporate and financial communications and capital markets experience, has established Consilium Strategic Communications as a leading global adviser to healthcare companies. This enables the team to make a positive contribution to all clients from day one.
Consilium Strategic Communications is seeped in healthcare experience and is adept at offering a diverse range of specialist capabilities with a measured but fresh-thinking approach. We offer our trusted insight and unbiased advice to enable clients to forge an impactful strategy in their engagement with the international media, financial markets community, patients' organisations, employees and other influential stakeholders.
Our experience spans Board advisory and senior executive counsel to public and privately held healthcare companies of all sizes across the entire spectrum of the sector: pharmaceutical, biotechnology, healthcare services, and medical device and diagnostic companies.
We work with global businesses in the Fortune 500, FTSE100, FTSE250, FTSEurofirst 300 and AIM, in addition to other public and privately held companies.